{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:32:18Z","timestamp":1773063138642,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00390","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T04:26:17Z","timestamp":1571891177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Vasculitis in a Child With the Hyper-IgM Variant of Ataxia-Telangiectasia"],"prefix":"10.3389","volume":"7","author":[{"given":"Anna K.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Nadasdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin W.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan K.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/adc.54.9.682","article-title":"Diagnostic considerations in ataxia-telangiectasia","volume":"54","author":"Jason","year":"1979","journal-title":"Arch Dis Child."},{"key":"B2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","article-title":"Immunodeficiency and infections in ataxia-telangiectasia","volume":"144","author":"Nowak-Wegrzyn","year":"2004","journal-title":"J Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","article-title":"Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype","volume":"128","author":"Micol","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/1744666X.2017.1292131","article-title":"The clinical significance of complete class switching defect in Ataxia telangiectasia patients","volume":"13","author":"Ghiasy","year":"2017","journal-title":"Expert Rev Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/adc.2008.149351","article-title":"Ataxia-telangiectasia patients presenting with hyper-IgM syndrome","volume":"94","author":"Noordzij","year":"2009","journal-title":"Arch Dis Child."},{"key":"B6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","article-title":"Ataxia-telangiectasia: immunodeficiency and survival","volume":"178","author":"van Os","year":"2017","journal-title":"Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3389\/fimmu.2018.02000","article-title":"Treatment of granulomas in patients with Ataxia telangiectasia","volume":"9","author":"Woelke","year":"2018","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/jdv.15568","article-title":"Cutaneous granulomas with primary immunodeficiency in children: a report of 17 new patients and a review of the literature","volume":"33","author":"Leclerc-Mercier","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/ijd.12765","article-title":"Cutaneous granulomas in the setting of primary immunodeficiency: a report of four cases and review of the literature","volume":"54","author":"Harp","year":"2015","journal-title":"Int J Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"O656","DOI":"10.1111\/1469-0691.12573","article-title":"Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency","volume":"20","author":"Bodemer","year":"2014","journal-title":"Clin Microbiol Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10875-019-0589-0","article-title":"Outcomes for nitazoxanide treatment in a case series of patients with primary immunodeficiencies and rubella virus-associated granuloma","volume":"39","author":"Perelygina","year":"2019","journal-title":"J Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2019.01.002","article-title":"A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas","volume":"200","author":"Minto","year":"2019","journal-title":"Clin Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12098-015-1852-x","article-title":"Ataxia telangiectasia masquerading as hyper IgM syndrome","volume":"83","author":"Rawat","year":"2016","journal-title":"Indian J Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s10875-012-9654-7","article-title":"Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia","volume":"32","author":"Ghosh","year":"2012","journal-title":"J Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1097\/MPH.0b013e3181bfd3d9","article-title":"Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation","volume":"32","author":"Pietrucha","year":"2010","journal-title":"J Pediatr Hematol Oncol."},{"key":"B17","first-page":"4","article-title":"Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome","volume":"20","author":"Aghamohammadi","year":"2010","journal-title":"J Investig Allergol Clin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-2008-1076736","article-title":"Different clinical and immunological presentation of ataxia-telangiectasia within the same family","volume":"39","author":"Soresina","year":"2008","journal-title":"Neuropediatrics."},{"key":"B19","first-page":"406","article-title":"Ataxia-telangiectasia in twins presenting as autosomal recessive hyper-immunoglobulin M syndrome","volume":"9","author":"Etzioni","year":"2007","journal-title":"Isr Med Assoc J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1034\/j.1399-3038.2003.00037.x","article-title":"Unusual and severe disease course in a child with Ataxia-telangiectasia","volume":"14","author":"Meyts","year":"2003","journal-title":"Pediatr Allergy Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1067\/mpd.2001.113356","article-title":"Lymphocytic interstitial pneumonitis, elevated IgM concentration, and hepatosplenomegaly in ataxia-telangiectasia","volume":"138","author":"Tangsinmankong","year":"2001","journal-title":"J Pediatr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41584-019-0254-2","article-title":"T follicular helper cells and T follicular regulatory cells in rheumatic diseases","volume":"15","author":"Deng","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","article-title":"The TH1 phenotype of follicular helper T cells indicates an IFN-\u03b3-associated immune dysregulation in patients with CD21low common variable immunodeficiency","volume":"141","author":"Unger","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1172\/JCI65728","article-title":"CXCR5+ T helper cells mediate protective immunity against tuberculosis","volume":"123","author":"Slight","year":"2013","journal-title":"J Clin Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"812781","DOI":"10.1155\/2013\/812781","article-title":"Adalimumab (TNF \u03b1 Inhibitor) therapy exacerbates IgA glomerulonephritis acute renal injury and induces lupus autoantibodies in a psoriasis patient","volume":"2013","author":"Wei","year":"2013","journal-title":"Case Rep Nephrol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.autrev.2014.05.005","article-title":"Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort","volume":"13","author":"Piga","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.mayocp.2012.04.011","article-title":"Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors","volume":"87","author":"Sokumbi","year":"2012","journal-title":"Mayo Clin Proc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.1073\/pnas.91.15.7007","article-title":"Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells","volume":"91","author":"Boussiotis","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/annrheumdis-2011-201270","article-title":"Anti-TNF treatment blocks the induction of T cell-dependent humoral responses","volume":"72","author":"Salinas","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ibd.20374","article-title":"Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab","volume":"14","author":"Di Sabatino","year":"2008","journal-title":"Inflamm Bowel Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/ar2718","article-title":"Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor","volume":"11","author":"Souto-Carneiro","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0182927","DOI":"10.1371\/journal.pone.0182927","article-title":"B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis","volume":"12","author":"Moura","year":"2017","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood."},{"key":"B34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4049\/jimmunol.180.2.688","article-title":"Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks","volume":"180","author":"Anolik","year":"2008","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00390\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T04:26:20Z","timestamp":1571891180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00390\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":35,"alternative-id":["10.3389\/fped.2019.00390"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00390","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"article-number":"390"}}